Anders Tuv Overview
- Firm
- Radforsk Investe...
- Primary Position
-
Chief Investment...
- Primary Industry
-
Healthcare
- Active Board Seats
-
8
- Med. Deal Size
-
- Med. Valuation
-
Anders Tuv General Information
Biography
Mr. Anders Tuv serves as Investment Director at The Norwegian Radium Hospital Research Foundation. He serves as a Board Member, Chair of the Audit Committee, and Member of the Remuneration Committee at Nykode. He serves as Board Member at Photocure, Simli, and ARTBIO. He serves as Chief Investment Officer at Radforsk Investeringsstiftelse. He serves as Chairman at Vaccibody. He serves as Board Member at ClexBio. He serves as the Chairman of the Nomination Committee at the Oslo Cancer Cluster. He served as Advisor at Norwegian Mycelium. He also serves as Board Member at OnDosis, He serves Board Member at Zelluna and Nextera. He served as the Chairman at OncoImmunity. He is the investment director of the early-stage life science investment company Radforsk, which is focused on immunotherapies and precision medicines. He is an experienced investment and business development professional with broad experience in the life science industry covering management positions, strategy, and business development, research collaborations, licensing deals, M&A, and IPOs. He holds several chairmen and non-executive director positions in Norwegian biotech companies. He holds an MBE degree.
Contact Information
Address
- Ullernchausseen 64
- 0379 Oslo
- Norway
Anders Tuv Positions (3)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
ARTBIO | Company | Co-Founder & Board Observer | Cambridge, MA | Biotechnology | |
Radforsk Investeringsstiftelse | Investor | Chief Investment Officer | Oslo, Norway | Venture Capital | |
Zelluna Immunotherapy | Company | Co-Founder & Board Member | Oslo, Norway | Drug Discovery |
Anders Tuv Board Seats (8)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
ARTBIO | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Cambridge, MA | |
Circio | Biotechnology | Publicly Held | Formerly VC-backed | Oslo, Norway | |
ClexBio | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Oslo, Norway | |
Nextera | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Oslo, Norway | |
Nykode | Biotechnology | Publicly Held | Formerly VC-backed | Oslo, Norway |
Anders Tuv Lead Partner on Deals (6)
Anders Tuv has been the lead partner on 6 deals. Their latest deal was with ARTBIO, a biotechnology company. The deal was made for on 21-Jun-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
ARTBIO | 21-Jun-2023 | Seed Round | Completed | Biotechnology | Cambridge, MA | |
NoMy | 15-Apr-2022 | Completed | Biotechnology | Oslo, Norway | ||
Photocure | 25-Jun-2020 | Completed | Pharmaceuticals | Oslo, Norway | ||
Zelluna Immunotherapy | 01-Jan-2016 | Completed | Drug Discovery | Oslo, Norway | ||
Nextera | 19-Aug-2012 | Early Stage VC | Completed | Drug Discovery | Oslo, Norway | |
Nykode | 30-Jul-2012 | Early Stage VC | Completed | Biotechnology | Oslo, Norway |
Anders Tuv Network (107)
Board Members (55)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Erlend Skagseth | Nykode | Sarsia Management | Oslo, Norway | |
Gustav Gaudernack | Zelluna Immunotherapy | Self | Oslo, Norway | |
OnDosis | GU Ventures | Molndal, Sweden | ||
Zelluna Immunotherapy | Self | Oslo, Norway | ||
Nykode | Self | Oslo, Norway |
Portfolio Executives (52)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Philippe Dasse | ARTBIO | Chief Technical Officer | 21-Jun-2023 | Cambridge, MA |
Emanuele Ostuni Ph.D | ARTBIO | Founding Chief Executive Officer & Board Member | 21-Jun-2023 | Cambridge, MA |
ARTBIO | Vice President of Finance & Finance Director | 21-Jun-2023 | Cambridge, MA | |
ARTBIO | Sceintific Co-Founder & Scientific Advisory Board Member | 21-Jun-2023 | Cambridge, MA | |
ARTBIO | Vice President of Clinical Development | 21-Jun-2023 | Cambridge, MA |
Anders Tuv FAQs
-
Who is Anders Tuv?
Mr. Anders Tuv serves as Investment Director at The Norwegian Radium Hospital Research Foundation.
-
How much does Anders Tuv typically invest?
Anders Tuv's median deal size is
. -
What is Anders Tuv’s main position?
Anders Tuv’s primary position is Chief Investment Officer.
-
How many active board seats does Anders Tuv hold?
Anders Tuv holds 8 board seats including ARTBIO, Circio, ClexBio, Nextera, and Nykode.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »